Hansoh Pharmaceutical Group Company Limited 3692
HKEX · Hong Kong SAR China · Health Technology
HKD 35.30+1.78 (+5.31%)
Market closed· · HKD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · HKD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
This article first appeared on GuruFocus. Hansoh Pharmaceutical Group Co Ltd (HNSPF) recently announced a total dividend of $0.04 per share, with the ex-dividend date set for 2026-09-22. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates.
Healthcare stocks were higher late Tuesday afternoon, with the NYSE Healthcare Index rising 2.3% and
Set to go public via a reverse merger, Avere has licensed from a prolific Chinese drugmaker rights to a potential threat to medicines like Skyrizi and Icotyde.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.